Effective interventions to reduce smoking-induced heart disease around the world: Time to act

Circulation

Volumn 112, Issue 4, 2005, Pages 456-458

  Barnoya, Joaquin ^a,b   Bialous, Stella Aguinaga ^c   Glantz, Stanton A ^b  

^a Unidad de Cirugia Cardiovascular de Guatemala   (Guatemala)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Tobacco Policy International   (United States)

Author keywords

Death; Editorials; Epidemiology; Prevention; Smoking

Indexed keywords

CARDIOVASCULAR RISK; EDITORIAL; HEALTH EDUCATION; HEART DISEASE; HEART INFARCTION; HUMAN; PATIENT COUNSELING; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION;

HEART DISEASES; HUMANS; SMOKING; WORLD HEALTH ORGANIZATION;

EID: 23044492776     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.554741     Document Type: Editorial

References (35)

1. Murray CJ, Lopez AD. The World Health Report 2002. Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002.
2. Ezzati M, Henly SJ, Thun MJ, Lopez AD. Role of smoking in global and regional cardiovascular mortality. Circulation. 2005;112: 489-497.
3. Mackay J, Mensah G, eds. The Atlas of Heart Disease and Stroke. Geneva, Switzerland: World Health Organization; 2004.
4. Schroeder SA. Tobacco control in the wake of the 1998 master settlement agreement. N Engl J Med. 2004;350:293-301.
5. Fichtenberg CM, Glantz SA. Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease. N Engl J Med. 2000;343:1772-1777.
6. Fichtenberg CM, Glantz SA. Effect of smoke-free workplaces on smoking behaviour: systematic review. BMJ. 2002;325:188.
7. Farkas AJ, Gilpin EA, Distefan JM, Pierce JP. The effects of household and workplace smoking restrictions on quitting behaviours. Tob Control. 1999;8:261-265.
8. Pechacek TF, Babb S. How acute and reversible are the cardiovascular risks of secondhand smoke? BMJ. 2004;328:980-983.
9. Barnoya J, Glantz S. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 2005;111:2684-2698.
10. Charlesworth A, Glantz S. Smoking in the movies increases adolescent smoking: a review. Pediatrics 2005. In press.
11. Mekemson C, Glantz SA. How the tobacco industry built its relationship with Hollywood. Tob Control. 2002;11:181-191.
12. Lambert A, Sargent JD, Glantz SA, Ling PM. How Philip Morris unlocked the Japanese cigarette market: lessons for global tobacco control. Tob Control. 2004;13:379-387.
13. Glantz SA. Smoking in movies: a major problem and a real solution. Lancet. 2003;362:258-259.
14. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746-2753.
15. Yach D, Bettcher D. Globalisation of tobacco industry influence and new global responses. Tob Control. 2000;9:206-216.
16. Barnoya J, Glantz S. Tobacco industry success in preventing regulation of secondhand smoke in Latin America: the "Latin Project." Tob Control. 2002;11:305-314.
17. Muggli ME, Hurt RD, Blanke DD. Science for hire: a tobacco industry strategy to influence public opinion on secondhand smoke. Nicotine Tab Res. 2003;5:303-314.
18. Drope J, Chapman S. Tobacco industry efforts at discrediting scientific knowledge of environmental tobacco smoke: a review of internal industry documents. J Epidemiol Community Health. 2001;55:588-594.
19. Dearlove JV, Bialous SA, Glantz SA. Tobacco industry manipulation of the hospitality industry to maintain smoking in public places. Tob Control. 2002;11:94-104.
20. Assunta M, Fields N, Knight J, Chapman S. "Care and feeding": the Asian environmental tobacco smoke consultants programme. Tob Control 2004;13:ii4-ii12.
21. Assunta M, Chapman S. "The world's most hostile environment": how the tobacco industry circumvented Singapore's advertising ban. Tob Control. 2004;13:ii51-ii57.
22. Ling PM, Glantz SA. Why and how the tobacco industry sells cigarettes to young adults: evidence from industry documents. Am J Public Health. 2002;92:908-916.
23. Why Is Tobacco a Public Health Priority? Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/tobacco/en/. Accessed April 29, 2005.
24. Lightwood JM, Glantz SA. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation. 1997; 96:1089-1096.
25. Lightwood J, Fleischmann KE, Glantz SA. Smoking cessation in heart failure: it is never too late. J Am Coll Cardiol. 2001;37:1683-1684.
26. Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev. 2003;(4): CD003041.
27. Ossip-Klein DJ, McIntosh S. Quitlines in North America: evidence base and applications. Am J Med Sci. 2003;326:201-205.
28. Zhu SH, Anderson CM, Tedeschi GJ, Rosbrook B, Johnson CE, Byrd M, Gutierrez-Terrell E. Evidence of real-world effectiveness of a telephone quitline for smokers. N Engl J Med. 2002;347:1087-1093.
29. World Health Organization. The Role of Health Professionals in Tobacco Control. Available at: http://www.who.int/tobacco/resources/publications/wntd/ 2005/bookletfinal_20april.pdf. Accessed April 29, 2005.
30. Sargent RP, Shepard RM, Glantz SA. Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. BMJ. 2004;328:977-980.
31. Code of Practice on Tobacco Control for Health Professional Organizations. Geneva, Switzerland: World Health Organization; 2004. Available at: http://www.who.int/tobacco/communications/events/codeofpractice/en/index. html. Accessed April 29, 2005.
32. Framework Convention Alliance for Tobacco Control home page. Available at: http://www.fctc.org. Accessed April 29, 2005.
33. WHO Framework Convention on Tobacco Control. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/tobacco/framework/ fctc_booklet_english.pdf. Accessed April 29, 2005.
34. Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States, 1995-1999. MMWR Morb Mortal Wkly Rep. 2002;51:300-303.
35. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293: 1861-1867.